Navigation Links
Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
Date:3/30/2012

SILVER SPRING, Md., March 30, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that Clotamin® is now an authorized product at Winn-Dixie. Clotamin will be available at 57 Winn-Dixie locations in South Florida starting in May 2012.

Winn-Dixie is headquartered in Jacksonville, Florida, and currently operates 482 stores throughout Alabama, Florida, Georgia, Louisiana and Mississippi.  In addition to filling prescriptions, Winn-Dixie pharmacies also provide preventive health screenings, medication counseling, immunizations, and other services.

"Winn-Dixie stores have a long history in Florida and have built close ties within the communities they serve.  We expect that their pharmacies will make an excellent venue for showcasing Clotamin and reach their many loyal customers," stated Mackie A. Barch, CEO of Sunpeaks.  "Moving forward, we believe that our success at increasing distribution in Florida will serve as a template for expanding Clotamin sales in other regions and also nationwide."

Clotamin® is the world's first specialized OTC multivitamin product designed exclusively for use by patients on Warfarin® or other anticoagulants (blood thinners). 

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Completes Acquisition of Healthcare Distribution Specialists LLC
2. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
3. Sunpeaks Ventures Announces Clotamin available on Walgreens.com
4. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
5. Sunpeaks Ventures to Participate in ECRM Conference and Expo
6. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
7. 7 Health Ventures Invests in Tulip Medical
8. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
9. ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
10. Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC
11. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 4, 2017  According to the Centers for Disease Control and Prevention ... . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the month. ... health insurance regulations. ... to get a flu shot is by the end of October, according ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association ... standards of excellence for the field of eating disorders, announces the opening of ... 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):